• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

胰腺癌原位移植瘤与皮下移植瘤代谢组学差异的鉴定及原因

Identification and causes of metabonomic difference between orthotopic and subcutaneous xenograft of pancreatic cancer.

作者信息

Zhan Bohan, Wen Shi, Lu Jie, Shen Guiping, Lin Xianchao, Feng Jianghua, Huang Heguang

机构信息

Department of Electronic Science, Fujian Provincial Key Laboratory of Plasma and Magnetic Resonance, Xiamen University, Xiamen 361005, China.

Department of General Surgery, Fujian Medical University Union Hospital, Fuzhou 350001, China.

出版信息

Oncotarget. 2017 May 22;8(37):61264-61281. doi: 10.18632/oncotarget.18057. eCollection 2017 Sep 22.

DOI:10.18632/oncotarget.18057
PMID:28977862
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5617422/
Abstract

Pancreatic ductal adenocarcinoma (PDAC) is one of the most lethal tumors. However, the methodological differences between orthotopic and subcutaneous xenograft (OX and SX) models will cause confusion in understanding its pathological mechanism and clinical relevance. In this study, SX and OX models were established by implanting Panc-1 and BxPC-3 cell strains under skin and on the pancreas of mice, respectively. The tumor tissue and serum samples were collected forH NMR spectroscopy followed by univariate and multivariate statistical analyses. As results, no obvious metabonomic difference was demonstrated in serum between the two models, however, the model- and cell strain-specific metabonomic differences were observed in tumor tissues. According to the KEGG analysis, ABC transporters, glycerophospholipid metabolism, purine metabolism and central carbon metabolism were identified to be the most significant components involved in metabonomic differences. Considering the methodological discrepancy in SX and OX models, such differences should be contributed to tumor microenvironment. In general, SX are not equivalent to OX models at molecular level. Subcutaneous transplantation displayed its inherent limitations though it offered a simple, inexpensive, reproducible and quantifiable advantage. And orthotopic transplantation may be favorable to simulate PDAC in patients due to its similar pathogenesis to human pancreatic cancer.

摘要

胰腺导管腺癌(PDAC)是最致命的肿瘤之一。然而,原位移植和皮下异种移植(OX和SX)模型之间的方法学差异会给理解其病理机制和临床相关性带来困惑。在本研究中,通过分别将Panc-1和BxPC-3细胞株植入小鼠皮肤下和胰腺上建立了SX和OX模型。收集肿瘤组织和血清样本进行核磁共振氢谱分析,随后进行单变量和多变量统计分析。结果显示,两种模型的血清中未表现出明显的代谢组学差异,然而,在肿瘤组织中观察到了模型和细胞株特异性的代谢组学差异。根据京都基因与基因组百科全书(KEGG)分析,ABC转运蛋白、甘油磷脂代谢、嘌呤代谢和中心碳代谢被确定为参与代谢组学差异的最显著成分。考虑到SX和OX模型的方法学差异,这种差异应归因于肿瘤微环境。总体而言,SX在分子水平上不等同于OX模型。皮下移植虽然具有简单、廉价、可重复和可量化的优点,但也显示出其固有的局限性。而原位移植由于其与人类胰腺癌相似的发病机制,可能更有利于模拟患者的PDAC。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5084/5617422/9641502d3787/oncotarget-08-61264-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5084/5617422/76e03a21f51a/oncotarget-08-61264-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5084/5617422/d8bd08ce1d0a/oncotarget-08-61264-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5084/5617422/c1df4b1d75ce/oncotarget-08-61264-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5084/5617422/194427959364/oncotarget-08-61264-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5084/5617422/baf2081cc73f/oncotarget-08-61264-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5084/5617422/9641502d3787/oncotarget-08-61264-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5084/5617422/76e03a21f51a/oncotarget-08-61264-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5084/5617422/d8bd08ce1d0a/oncotarget-08-61264-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5084/5617422/c1df4b1d75ce/oncotarget-08-61264-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5084/5617422/194427959364/oncotarget-08-61264-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5084/5617422/baf2081cc73f/oncotarget-08-61264-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5084/5617422/9641502d3787/oncotarget-08-61264-g006.jpg

相似文献

1
Identification and causes of metabonomic difference between orthotopic and subcutaneous xenograft of pancreatic cancer.胰腺癌原位移植瘤与皮下移植瘤代谢组学差异的鉴定及原因
Oncotarget. 2017 May 22;8(37):61264-61281. doi: 10.18632/oncotarget.18057. eCollection 2017 Sep 22.
2
Non-invasively predicting differentiation of pancreatic cancer through comparative serum metabonomic profiling.通过比较血清代谢组学分析无创预测胰腺癌的分化。
BMC Cancer. 2017 Nov 2;17(1):708. doi: 10.1186/s12885-017-3703-9.
3
Metabonomic changes from pancreatic intraepithelial neoplasia to pancreatic ductal adenocarcinoma in tissues from rats.大鼠组织中从胰腺上皮内瘤变到胰腺导管腺癌的代谢组学变化。
Cancer Sci. 2016 Jun;107(6):836-45. doi: 10.1111/cas.12939. Epub 2016 May 17.
4
In Vivo Flow Cytometric Evaluation of Circulating Metastatic Pancreatic Tumor Cells after High-Intensity Focused Ultrasound Therapy.高强度聚焦超声治疗后循环胰腺转移瘤细胞的体内流式细胞术评估。
Cytometry A. 2020 Sep;97(9):900-908. doi: 10.1002/cyto.a.24014. Epub 2020 Apr 19.
5
Metabonomic alterations from pancreatic intraepithelial neoplasia to pancreatic ductal adenocarcinoma facilitate the identification of biomarkers in serum for early diagnosis of pancreatic cancer.从胰腺上皮内瘤变到胰腺导管腺癌的代谢组学改变有助于识别血清中的生物标志物,用于胰腺癌的早期诊断。
Mol Biosyst. 2016 Aug 16;12(9):2883-92. doi: 10.1039/c6mb00381h.
6
Understanding metabolomic characteristics of pancreatic ductal adenocarcinoma by HR-MAS NMR detection of pancreatic tissues.通过胰腺组织的高分辨率魔角旋转核磁共振检测来理解胰腺导管腺癌的代谢组学特征。
J Pharm Biomed Anal. 2020 Oct 25;190:113546. doi: 10.1016/j.jpba.2020.113546. Epub 2020 Aug 15.
7
Expression of DRD2 Is Increased in Human Pancreatic Ductal Adenocarcinoma and Inhibitors Slow Tumor Growth in Mice.DRD2 在人胰腺导管腺癌中表达增加,抑制剂可减缓小鼠肿瘤生长。
Gastroenterology. 2016 Dec;151(6):1218-1231. doi: 10.1053/j.gastro.2016.08.040. Epub 2016 Aug 28.
8
Clinical, molecular and genetic validation of a murine orthotopic xenograft model of pancreatic adenocarcinoma using fresh human specimens.使用新鲜人类标本对胰腺腺癌小鼠原位异种移植模型进行临床、分子和基因验证。
PLoS One. 2013 Oct 18;8(10):e77065. doi: 10.1371/journal.pone.0077065. eCollection 2013.
9
A fast, simple, and cost-effective method of expanding patient-derived xenograft mouse models of pancreatic ductal adenocarcinoma.一种快速、简单且具有成本效益的方法,用于扩展胰腺导管腺癌患者来源异种移植小鼠模型。
J Transl Med. 2020 Jun 24;18(1):255. doi: 10.1186/s12967-020-02414-9.
10
Diphenylbutylpiperidine Antipsychotic Drugs Inhibit Prolactin Receptor Signaling to Reduce Growth of Pancreatic Ductal Adenocarcinoma in Mice.二苯丁基哌啶类抗精神病药物通过抑制催乳素受体信号通路抑制胰腺导管腺癌在小鼠中的生长。
Gastroenterology. 2020 Apr;158(5):1433-1449.e27. doi: 10.1053/j.gastro.2019.11.279. Epub 2019 Nov 29.

引用本文的文献

1
Identifying the Morphological and Molecular Features of a Cell-Based Orthotopic Pancreatic Cancer Mouse Model during Growth over Time.随着时间的推移,识别基于细胞的原位胰腺癌小鼠模型生长过程中的形态和分子特征。
Int J Mol Sci. 2024 May 22;25(11):5619. doi: 10.3390/ijms25115619.
2
Progress in building clinically relevant patient-derived tumor xenograft models for cancer research.用于癌症研究的具有临床相关性的患者来源肿瘤异种移植模型构建进展。
Animal Model Exp Med. 2023 Oct;6(5):381-398. doi: 10.1002/ame2.12349. Epub 2023 Sep 7.
3
Chemical-induced lung tumor in Tg-rasH2 mice: a novel mouse tumor model to assess immune checkpoint inhibitors combined with a chemotherapy drug.

本文引用的文献

1
Pancreatic stellate cells support tumour metabolism through autophagic alanine secretion.胰腺星状细胞通过自噬性丙氨酸分泌来支持肿瘤代谢。
Nature. 2016 Aug 25;536(7617):479-83. doi: 10.1038/nature19084. Epub 2016 Aug 10.
2
Metabonomic alterations from pancreatic intraepithelial neoplasia to pancreatic ductal adenocarcinoma facilitate the identification of biomarkers in serum for early diagnosis of pancreatic cancer.从胰腺上皮内瘤变到胰腺导管腺癌的代谢组学改变有助于识别血清中的生物标志物,用于胰腺癌的早期诊断。
Mol Biosyst. 2016 Aug 16;12(9):2883-92. doi: 10.1039/c6mb00381h.
3
Metabonomic changes from pancreatic intraepithelial neoplasia to pancreatic ductal adenocarcinoma in tissues from rats.
化学诱导的Tg-rasH2小鼠肺癌:一种评估免疫检查点抑制剂联合化疗药物的新型小鼠肿瘤模型。
J Toxicol Pathol. 2022 Oct;35(4):321-331. doi: 10.1293/tox.2022-0040. Epub 2022 Jun 26.
4
Metabolic profiling of induced acute pancreatitis and pancreatic cancer progression in a mutant Kras mouse model.突变型Kras小鼠模型中诱导性急性胰腺炎和胰腺癌进展的代谢谱分析
Front Mol Biosci. 2022 Aug 25;9:937865. doi: 10.3389/fmolb.2022.937865. eCollection 2022.
5
Functional Drug Screening in the Era of Precision Medicine.精准医学时代的功能性药物筛选
Front Med (Lausanne). 2022 Jul 8;9:912641. doi: 10.3389/fmed.2022.912641. eCollection 2022.
6
Exercise-induced engagement of the IL-15/IL-15Rα axis promotes anti-tumor immunity in pancreatic cancer.运动诱导的 IL-15/IL-15Rα 轴激活促进胰腺癌中的抗肿瘤免疫。
Cancer Cell. 2022 Jul 11;40(7):720-737.e5. doi: 10.1016/j.ccell.2022.05.006. Epub 2022 Jun 2.
7
Metabolomics based plasma biomarkers for diagnosis of oral squamous cell carcinoma and oral erosive lichen planus.基于代谢组学的血浆生物标志物用于口腔鳞状细胞癌和口腔糜烂性扁平苔藓的诊断
J Cancer. 2022 Jan 1;13(1):76-87. doi: 10.7150/jca.59777. eCollection 2022.
8
Functional genomics approaches to improve pre-clinical drug screening and biomarker discovery.功能基因组学方法在改善临床前药物筛选和生物标志物发现中的应用。
EMBO Mol Med. 2021 Sep 7;13(9):e13189. doi: 10.15252/emmm.202013189. Epub 2021 Jul 13.
9
Multi-omic profiling of lung and liver tumor microenvironments of metastatic pancreatic cancer reveals site-specific immune regulatory pathways.对转移性胰腺癌肺和肝肿瘤微环境的多组学分析揭示了特定于部位的免疫调节途径。
Genome Biol. 2021 May 13;22(1):154. doi: 10.1186/s13059-021-02363-6.
10
Preclinical models of pancreatic ductal adenocarcinoma: challenges and opportunities in the era of precision medicine.胰腺导管腺癌的临床前模型:精准医学时代的挑战与机遇。
J Exp Clin Cancer Res. 2021 Jan 5;40(1):8. doi: 10.1186/s13046-020-01787-5.
大鼠组织中从胰腺上皮内瘤变到胰腺导管腺癌的代谢组学变化。
Cancer Sci. 2016 Jun;107(6):836-45. doi: 10.1111/cas.12939. Epub 2016 May 17.
4
Prognostic significance of L-type amino acid transporter 1 (LAT1) expression in cutaneous melanoma.L型氨基酸转运体1(LAT1)在皮肤黑色素瘤中的表达的预后意义
Melanoma Res. 2015 Oct;25(5):399-405. doi: 10.1097/CMR.0000000000000181.
5
The clinical significance of FRAT1 and ABCG2 expression in pancreatic ductal adenocarcinoma.FRAT1和ABCG2在胰腺导管腺癌中的表达的临床意义。
Tumour Biol. 2015 Dec;36(12):9961-8. doi: 10.1007/s13277-015-3752-0. Epub 2015 Jul 16.
6
Metabolic rewiring of pancreatic ductal adenocarcinoma: New routes to follow within the maze.胰腺导管腺癌的代谢重编程:迷宫中可供追寻的新路径。
Int J Cancer. 2016 Feb 15;138(4):787-96. doi: 10.1002/ijc.29501. Epub 2015 Mar 18.
7
Cancer statistics, 2015.癌症统计数据,2015 年。
CA Cancer J Clin. 2015 Jan-Feb;65(1):5-29. doi: 10.3322/caac.21254. Epub 2015 Jan 5.
8
Organoid models of human and mouse ductal pancreatic cancer.人类和小鼠胰腺导管癌的类器官模型
Cell. 2015 Jan 15;160(1-2):324-38. doi: 10.1016/j.cell.2014.12.021. Epub 2014 Dec 31.
9
Metabolic imaging of pancreatic ductal adenocarcinoma detects altered choline metabolism.胰腺导管腺癌的代谢成像检测到胆碱代谢改变。
Clin Cancer Res. 2015 Jan 15;21(2):386-95. doi: 10.1158/1078-0432.CCR-14-0964. Epub 2014 Nov 4.
10
Establishment of and comparison between orthotopic xenograft and subcutaneous xenograft models of gallbladder carcinoma.胆囊癌原位异种移植模型与皮下异种移植模型的建立及比较
Asian Pac J Cancer Prev. 2014;15(8):3747-52. doi: 10.7314/apjcp.2014.15.8.3747.